ArticleFrontiers in pharmacology2023

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial.

Farzaneh Dastan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.